Streetbeat News

Revenues

BCLI

BrainStorm Cell Therapeutics provided updates on its NurOwn stem cell therapy for ALS, including resolving CMC FDA questions, beginning the PIIIb rollout, raising $4M, and setting up a commercialization team. Despite a ~5% value range reduction due to dilution, the investment hypothesis remains strong with potential >10x returns. The company is also exploring non-dilutive grant funds.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:33 pm

TMO

Thermo Fisher Scientific Inc. (NYSE: TMO) reported a slight dip in Q2 revenue but beat earnings expectations. The company completed the acquisition of Olink and raised its annual profit outlook. Despite a premarket stock dip, the outlook remains positive.

Portfolio Pulse from Vandana Singh

July 24, 2024 | 12:32 pm

LW

Lamb Weston Holdings (NYSE:LW) reported Q4 earnings of $0.78 per share, missing the analyst estimate of $1.26 by 38.1%. Sales were $1.61 billion, also below the $1.70 billion estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:32 pm

SPY

USA retail inventories excluding autos increased by 0.2% in June, indicating a modest growth in retail stock levels.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:31 pm

CSIQ

Canadian Solar's subsidiary, Recurrent Energy, has secured a €50 million loan from the European Investment Bank to develop a solar energy portfolio in Italy. This move strengthens Recurrent Energy's position in Italy's clean energy market and supports Europe's renewable energy goals.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:30 pm

SPY

The USA Goods Trade Balance for June was reported at -$96.84 billion, better than the estimated -$98.80 billion and the prior -$99.37 billion.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:30 pm

PFE

SGMO

Sangamo Therapeutics announced that Pfizer's Phase 3 trial of Giroctocogene Fitelparvovec met its primary and key secondary objectives. Sangamo is eligible for up to $220 million in milestone payments and 14%-20% royalties if the therapy is approved and commercialized.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:28 pm

PROG

PROG shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:27 pm

TSEM

Tower Semiconductor Ltd (NASDAQ:TSEM) reported a 1.7% decline in Q2 2024 revenue to $351.2 million, beating analyst estimates. Adjusted EPS of $0.53 also surpassed expectations. Despite the revenue decline, gross profit and operating profit increased. The company expects Q3 revenue of $370 million. Shares fell 2.46% premarket.

Portfolio Pulse from Anusuya Lahiri

July 24, 2024 | 12:24 pm

CLW

Clearwater Paper Corporation (CLW) has announced the sale of its tissue business to Sofidel America for $1.06 billion. This transaction is expected to reduce Clearwater Paper's net debt and support its transformation into a leading independent supplier of paperboard to North American converters.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:24 pm